DUBLIN--(BUSINESS WIRE)--The "Indian Shared Mobility Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The research service assesses growth opportunities…
Trestle gains access to pioneering kidney stem cell biology differentiation protocols from the laboratory of Dr. Ryuichi Nishinakamura SAN DIEGO--(BUSINESS…
NEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)--#AI--WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management…
--CSO Kevin Foley to highlight FDA IND clearance for Ranok’s first clinical program, RNK05047, that was developed using the company’s…
The first-of-its-kind online service connects independent specialty stores and designers with handicrafts, gifts and home décor merchandise from India DALLAS--(BUSINESS…
DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…
DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…
DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…
BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…
BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…
BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…
- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology - HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals…
- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology - HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals…
- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology - HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Buy Now Pay Later Business and Investment Opportunities - 75+ KPIs on Buy Now Pay Later…